The vitamin E status among glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E.
The effect of oral vitamin E therapy (800 IU/day) on correcting haematologic variables and on raising the plasma vitamin E level among glucose-6 phosphate dehydrogenase deficient subjects with history of hemolysis was studied. After 16 week period there was a positive response to vitamin E administration presented by sustained improvement in blood hemoglobin and plasma vitamin E concentrations. In the meanwhile, the vitamin E supplementation led to reduced reticulocytosis and control % hemolysis.
Eldamhougy
S
S
National Research Center, Nutrition Laboratory, Giza, Dokki, Egypt.
Elhelw
Z
Z
Yamamah
G
G
Hussein
L
L
Fayyad
I
I
Fawzy
D
D
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood* / Q000188:drug therapy; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007223:Infant; D008297:Male; D012156:Reticulocytes / Q000187:drug effects; D014810:Vitamin E / Q000008:administration & dosage / Q000097:blood*
D014810:Vitamin E